ScreenPlus: A Comprehensive Flexible Multi-disorder Newborn Screening Program

Go Back to All Clinical Trials

ScreenPlus: A Comprehensive Flexible Multi-disorder Newborn Screening Program

Brief description of study

Shortly after birth, all New York babies have a routine newborn screening (NBS) test that checks for more than 50 treatable disorders. ScreenPlus is a research study where babies are screened for an additional 14 rare disorders that are not currently on NY’s routine NBS panel. All of the disorders on the ScreenPlus panel have an approved treatment or an investigational therapy that is currently being tested in a clinical trial. ScreenPlus will help us understand how well NBS works for these disorders.

For more information, please reach out to ScreenPlus@nyulangone.org.

Clinical Study Identifier: s22-00570

Principal Investigator: Sean M. Bailey.

Other Investigator: Rishi M. Lumba.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies